Pharmaceutical Products Companies By Gross Profit

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Gross Profit
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Gross ProfitEfficiencyMarket RiskExp Return
1MRNA Moderna
10.55 B
(0.38)
 3.19 
(1.20)
2MRVI Maravai Lifesciences Holdings
714.04 M
(0.12)
 6.04 
(0.75)
3DVAX Dynavax Technologies
448.22 M
 0.05 
 2.47 
 0.12 
4MOLN Molecular Partners AG
138.85 M
 0.00 
 7.40 
(0.04)
5ME 23Andme Holding Co
132.94 M
(0.14)
 6.56 
(0.90)
6VCEL Vericel Corp Ord
109.79 M
 0.09 
 3.06 
 0.28 
7MIRM Mirum Pharmaceuticals
64.69 M
 0.05 
 2.51 
 0.13 
8MEIP MEI Pharma
48.82 M
(0.06)
 2.62 
(0.15)
9MNKD MannKind Corp
42.27 M
 0.19 
 2.21 
 0.41 
10XOMAP XOMA Corp
37.99 M
 0.07 
 0.77 
 0.05 
11XOMAO XOMA Corporation
37.99 M
 0.12 
 0.41 
 0.05 
12VERU Veru Inc
30.59 M
(0.11)
 3.82 
(0.41)
13SNYR SYNERGY CHC P
25.65 M
 0.28 
 257.65 
 73.33 
14DTIL Precision BioSciences
25.1 M
(0.16)
 2.69 
(0.43)
15DRRX Durect
16.48 M
(0.15)
 4.27 
(0.63)
16MGTX MeiraGTx Holdings PLC
15.92 M
 0.16 
 3.74 
 0.59 
17EQ Equillium
15.76 M
(0.04)
 7.75 
(0.32)
18MDWD Mediwound
13.16 M
(0.03)
 3.13 
(0.11)
19DNTH Dianthus Therapeutics
6.42 M
(0.11)
 3.67 
(0.42)
20MIST Milestone Pharmaceuticals
5 M
 0.14 
 2.96 
 0.41 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY